Hui Liu

29PUBLICATIONS
56CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 27, 2026
CD73 inhibitor enhances the antitumor activity of selinexor in multiple myeloma by restoring the activation of CD8+ T cells.

|Jul 09, 2026
A Comprehensive Landscape of B Symptoms in Mantle Cell Lymphoma Reveals Heterogeneity Associated With Different Primary Sites.

|May 14, 2026
Pre-Transplant MRD Negativity and Age Under 40 Predict Superior Long-Term Survival in Relapsed/Refractory B-ALL After CAR-T Therapy Bridging to Haploidentical HSCT: A Multicenter Retrospective Study With 6-Year Follow-Up.

|May 05, 2026
Hemophagocytic Lymphohistiocytosis After CAR T-Cell Therapy: A Systematic Review and Meta-Analysis.

|Apr 22, 2026
Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients With Relapsed/Refractory Acute Myeloid Leukemia.

|Mar 26, 2026
Current progress of CDC20 in cancer development and targeting CDC20 for cancer therapy.

Yingtong Chen, Shuang Gao, Ping Yang

Pageof 5

Frequent Collaborators

7 joint publications

Weilong Zhang

3 joint publications

Hui Liu

2 joint publications

Qingqing Cai

1 joint publications

Wei Zhang